Jonathan Goldman - Director at Avalo Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
AVTX on Nasdaq
All Insider Reports
All Insider Reports

Jonathan Goldman - trading volume in the past year for Avalo Therapeutics, Inc.

Holdings reported by Jonathan Goldman for Avalo Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 6,333 $53,577 $8.46 28 Mar 2025 Direct Common Stock
Common Stock 0 $0 $14.35 14 Nov 2025 Direct
Stock Option (Right to Buy) 16,400 14 Nov 2025 Direct Common Stock

Transactions reported by Jonathan Goldman for Avalo Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.